MedTrace Logo

Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

NCT00496574 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-02-07

No results posted yet for this study

Summary

The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy after three years of SIT in children with asthma.

Conditions

Interventions

BIOLOGICAL

Novo Helisen Depot, Phostal

subcutaneous immunotherapy

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Agnieszka Sobocińska, MD · Department of Pediatrics and Allergy, Medical University of Lodz, Lodz, Poland

  • Iwona Stelmach, MD PhD Prof · Department of Pediatrics and Allergy, Medical University of Lodz, Lodz, Poland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00496574 on ClinicalTrials.gov